NorthWest Biotherapeutics Inc (NWBO)

[ae kusterer]

It will after the approval.

Les said fifteen types of cancers were treated with DCVax-L through UK compassionate use program. "Most of them blockbuster drugs"
Which BP wouldn't want franchise?

Be patient for the approval.

In 10k released on March 5, it said a case study paper was accepted for publication. Four months later, we haven't seen the publication. Is it normal that the paper has not been published at least four months after its acceptance? I don't think it is. If we check the case study papers by professor Ashkan, none of his case study papers took long time to publish after the acceptance.

I assume the case study contains some information that might be related to the filing. For instance, we only guess that the combination of DCVax-L with Poly-ICLC was adopted. We have no solid proof. The paper can certainly provide some insights. So the publication of the case study paper will come after the approval.
https://www.cancervic.org.au/cancer-information/types-of-cancer/brain_tumour/treatment_for_brain_spinal_cor.html